1. Danish Medicines Agency. Conclusions and recommendations from the Pharmaceutical Forum. Danish Medicines Agency [online] , (2010).
2. Luce, B. R. et al. EBM, HTA, and CER: clearing the confusion. Millbank Q. 88, 256–276 (2010).
3. European Medicines Agency. European Medicines Agency recommends measures to manage contamination of heparin-containing medicines. European Medicines Agency [online] , (2008).
4. European Medicines Agency. Studies assessed by the EMEA indicate no increased risk of developing cancer for patients who have taken Viracept contaminated with ethyl mesilate. European Medicines Agency [online] . (2008).
5. Dal Pan, G. J., Blackburn, S. & Karwoski, C. in Textbook of Pharmacoepidemiology (eds Strom, B. L. & Kimmel, S. E.) (John Wiley & Sons, New Jersey), (in the press).